2005
DOI: 10.1038/sj.gt.3302657
|View full text |Cite
|
Sign up to set email alerts
|

Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
76
0
1

Year Published

2007
2007
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 77 publications
(82 citation statements)
references
References 36 publications
5
76
0
1
Order By: Relevance
“…It was earlier reported that VSV-GED had strong improvement of transduction efficiency over GP64 control [11]. To understand if the disparity between the observation in this study and the previous study [11] was due to difference in MOI used, a transduction was carried out in BHK-21 cells using the high MOI of 50 like in the previous study.…”
Section: Discussionmentioning
confidence: 65%
See 3 more Smart Citations
“…It was earlier reported that VSV-GED had strong improvement of transduction efficiency over GP64 control [11]. To understand if the disparity between the observation in this study and the previous study [11] was due to difference in MOI used, a transduction was carried out in BHK-21 cells using the high MOI of 50 like in the previous study.…”
Section: Discussionmentioning
confidence: 65%
“…The observed variation in VSV-G mediated transduction efficiency in different cell types could be due to difference in receptor(s) expression. After confirming that VSV-G pseudotyping enhanced the transduction of mammalian cells by the baculovirus, it was investigated if VSV-GED, a truncated version of VSV-G, comprising of partial G-stem of ectodomain in juxtaposition with the TM and CT domains of VSV-G, was sufficient enough for increasing baculovirus-mediated gene delivery, as reported earlier [4,11]. Therefore the transduction was evaluated for recombinant baculovirus encoding AcGFP under CMV promoter, pseudotyped with either full-length VSV-G or its truncated version.…”
Section: Discussionmentioning
confidence: 86%
See 2 more Smart Citations
“…22 Another appealing application of baculovirus is in vivo gene delivery, but most previous in vivo studies delivered only reporter genes into animal models. 23 28 show that a baculovirus expressing diphtheria toxin A inhibits the glioma xenograft growth in the rat brain, suggesting the potentials of baculovirus in cancer therapy. However, the applications of baculovirus in mesenchymal stem cell engineering and bone repair have yet to be reported.…”
Section: Discussionmentioning
confidence: 99%